期刊文献+

紫杉醇通过MLK_3/JNK_3信号通路对海马神经元损伤的保护作用 被引量:3

Effect and mechanism of paclitaxel on neuronal injury induced by cerebral ischemia/reperfusion through MLK_3/JNK_3 signaling pathway
原文传递
导出
摘要 目的研究紫杉醇对脑缺血/再灌注后海马神经元损伤的保护作用的分子机制。方法采用SD大鼠四动脉结扎脑缺血模型(4-VO),在缺血前30 min脑室注射紫杉醇(4、8、12、20μg/kg),应用免疫沉淀及免疫印迹方法分析JNK3/MLK3/Fas-L的蛋白表达量和激活情况;焦油紫染色,观察紫杉醇对大鼠海马神经元的作用。结果紫杉醇显著抑制了脑缺血/再灌注后JNK3/MLK3/Fas-L的激活;焦油紫染色观察,紫杉醇对大鼠海马神经元的凋亡有明显的抑制作用。结论紫杉醇对脑缺血/再灌注诱导的海马神经元的损伤具有保护作用,这种保护作用和JNK3介导的信号通路密切相关,为临床治疗脑中风提供理论依据。 Objective To study the effects and molecular mechanisms of paclitaxel (P) on the brain injury of hippocampal neurons induced by ischemia/reperfusion ( I/ R). Methods Westen blot assay was used to examine the JNK3/MLK3 activation in the four-vessel occlusion (4-VO) model of Sprague- Dawley rats. And cresly violet staining was to demonstrate the survival of nerve cell in I/R. Results Transient cerebral ischemia followed by reperfusion caused a significant increase in phosphorylation of JNK3/MLK3/Fas-L. Administration of paclitaxel 30 rain before ischemia caused a pronounced decrease phosphorylation of JNK3/MLK3/Fas-L, but the administration of the vehicles DMSO had no effect. Cresyl violet staining showed that neurons in hippocampi subjected to paclitaxel (30 min before, Pre-ischemia 4 μg/kg, 8 μg/kg, 12μg/kg, 20μg/kg) were protected significantly compared with those without paclitaxel. Conclusion Paclitaxel has neuroprotective effect against I/R induced neuronal cell death and this effect correlated with JNK3 signaling pathway. These findings might provide some clues to understand the mechanism underlying ischemia tolerance and to finding clinical therapies for stroke.
出处 《苏州大学学报(医学版)》 CAS 2012年第1期1-5,共5页 Suzhou University Journal of Medical Science
基金 国家自然科学基金(项目编号:81171075) 江苏省教育厅自然科学基金(项目编号:08KJB180010 11KJB310012) 徐州医学院人才基金(项目编号:2010KJZ13)
关键词 紫杉醇 脑缺血/再灌注 JNK3(c-Jun N-TERMINAL kinase) MLK3(mixed LINEAGE kinase) FAS-L paclitaxel cerebral ischemia reperfusion JNK3 MLK3 Fas-L
  • 相关文献

参考文献13

  • 1刘敏,李智慧,许玉杰.纳米化紫杉醇与电离辐射对KB细胞联合作用的研究[J].苏州大学学报(医学版),2011,31(1):16-20. 被引量:3
  • 2王庆才,毛一香,陈凯,朱春荣,殷红.多西紫杉醇/顺铂/5-氟脲嘧啶联合治疗进展期胃癌的近期疗效观察[J].苏州大学学报(医学版),2008,28(3):477-479. 被引量:5
  • 3Li GB,Alexander F,Brandon J.et al.Stabilization of thecyclin-dependent kinase 5 activator,p35,by paclitaxel de-creases b-amyloid toxicity in cortical neurons[J].Neuro-chem,2003,84(1):347-362.
  • 4Chen J,Li C,Pei DS,et al.GluR6-Containing KA Receptor Mediates the Activation of p38 MAP Kinase in RatHippocampal CA1 Region During Brain Ischemia Injury[J].Hippocampus,2009,19(1):79-89.
  • 5Qi SH,Liu Y,Wang WW,et al.Neuroprotection of etha-nol against cerebral ischemia/reperfusion induced brain in-jury through GABA receptor activation[J].Brain Res,2009,1276(1):151-158.
  • 6Qi SH,Guan QH,Wang M,et al.Action of ERK5 in is-chemic tolerance suggests its probable participation in thesignaling mechanism[J].J.Receptors and Signal Trans-duction,2009,29(1):34-39.
  • 7Nihalani D,meyer D,Pajni S,et al.Mixed lineage ki-nase-dependent JNK activation is governed by interactionsof scaffold protein JIP with MAPK module components[J].EMBO J,2001,20(13):3447-3458.
  • 8Pei DS,Wang XT,Liu Y,et al.Neuroprotection againstischaemic brain injury by a Gluk2-9c peptide containingthe TAT protein transduction sequence[J].Brain,2006,129(2):465-479.
  • 9Guan QH,Pei DS,Zong YY,et al.Neuroprotection a-gainst ischemic brain injury by a small peptide inhibitor ofc-Jun N-terminal kinase(JNK)Via nuclear and non-nu-clear pathways[J].Neurosci,2006,139(2):609-627.
  • 10Pan J,Zhang QG,Zhang GY.The neuroprotective effectsof K252a through inhibiting MLK3/MKK7/JNK3 signalingpathway on ischemic brain injury in rat hippocampal CA1region[J].Neurosci,2005,131(1):147-159.

二级参考文献16

  • 1唐朝晖,钟德玝.紫杉醇抗肿瘤的分子机制[J].中国临床康复,2006,10(27):125-127. 被引量:45
  • 2王晓军,徐效益,刘国津,景遐斌.化学键合紫杉醇纳米微粒对Lewis肺癌细胞株的增殖抑制作用[J].广东医学,2007,28(2):175-177. 被引量:6
  • 3刘敏,许玉杰.抗肿瘤药物靶向载体系统的研究与开发[J].药学进展,2007,31(3):97-103. 被引量:3
  • 4Kurtin S E. Systemic therapies for squamous cell carcinoma of the head and neck[J], Semin Oncol Nurs,2009,25(3) : 183 - 192.
  • 5Johnson N. Tabacco use and oral cancer: a globle perspective[J]. Dent Educ,2001, 65(4) :328 -339.
  • 6Tisher R, Colevas AO, Norris CM, et al. A Phase I / II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prog-nosis squamous cell carcinoma of the head and neck [ J ]. Cancer,2002,95 (7) :1472 - 1481.
  • 7Andreas du B, Hans-J Luck, Wener M, et al. Carppboplation plus paclitxel as first-line chemotherapy in previously untreated advanced ovarian cancer[J]. Semin oncol, 1997, 24(11) :28 -32.
  • 8周际昌.实用肿瘤内科学[M].北京:人民卫生出版社,1997.72.
  • 9张天泽,徐光炜.肿瘤学(中册)[M].天津:天津科学技术出版社,1998.1421.
  • 10Ajani JA,Van Custem E,Moiseyenko FC, et all. Docetaxel(D), cisplatin, 5-fluorouracil (F) for chemotherapynaive patients with metastatic or locally recurrent,unresectable gastric carcinoma:Interim results of a randomized phase Ⅲ trial (V 325)[J]. Proc Am Soc Cli Clin Oncol, 2003,22:999.

共引文献6

同被引文献37

引证文献3

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部